Height and lymphoblastic leukaemia.

Abstract
Two hundred and thirty six children with untreated lymphoblastic leukaemia were compared for height with the normal population by calculation of their mean standard deviation score. As a group, they proved to be significantly taller (P less than 0.0001), which gives support to the theory that growth hormone or a somatomedin may be involved in the development of the disease.